Salvage therapy of refractory severe aplastic anemia by decreasing cyclosporine dose regimen.

about

Model-Based Determination of Effective Blood Concentrations of Cyclosporine for Neutrophil Response in the Treatment of Severe Aplastic Anemia in Children.Confounding effect of cyclosporine dosing when comparing horse and rabbit antithymocyte globulin in patients with severe aplastic anemia.

P2860

Q35967925-FF3C7B53-2AD3-4F4D-8284-8FCBA7FC2429 Q42573838-931ACB9E-15C3-43F1-A476-2849D9FD9D36

P2860

Salvage therapy of refractory severe aplastic anemia by decreasing cyclosporine dose regimen.

Item

http://www.wikidata.org/entity/Q44157333

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Salvage therapy of refractory ...... ing cyclosporine dose regimen.

@en

Salvage therapy of refractory ...... ing cyclosporine dose regimen.

@nl

type

Item

label

Salvage therapy of refractory ...... ing cyclosporine dose regimen.

@en

Salvage therapy of refractory ...... ing cyclosporine dose regimen.

@nl

prefLabel

Salvage therapy of refractory ...... ing cyclosporine dose regimen.

@en

Salvage therapy of refractory ...... ing cyclosporine dose regimen.

@nl

P1476

Salvage therapy of refractory ...... ing cyclosporine dose regimen.

@en

P2093

Amandine Bertrand

http://www.w3.org/2001/XMLSchema#string

Dominique Plantaz

http://www.w3.org/2001/XMLSchema#string

Mickael Philippe

http://www.w3.org/2001/XMLSchema#string

Nathalie Bleyzac

http://www.w3.org/2001/XMLSchema#string

Yves Bertrand

http://www.w3.org/2001/XMLSchema#string

P2860

Current concepts in the pathophysiology and treatment of aplastic anemia

Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

Interleukin 2 signaling is required for CD4(+) regulatory T cell function.

Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis.

Deficient CD4+ CD25+ FOXP3+ T regulatory cells in acquired aplastic anemia.

Limited heterogeneity of T cell receptor BV usage in aplastic anemia.

Rabbit ATG but not horse ATG promotes expansion of functional CD4+CD25highFOXP3+ regulatory T cells in vitro

Horse versus rabbit antithymocyte globulin in acquired aplastic anemia

Phase II study of rabbit anti-thymocyte globulin, cyclosporine and granulocyte colony-stimulating factor in patients with aplastic anemia and myelodysplastic syndrome

Molecular mechanisms underlying FOXP3 induction in human T cells.

P304

172-176

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/EJH.12220

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-12-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24147892

http://www.w3.org/2001/XMLSchema#string

Salvage therapy of refractory severe aplastic anemia by decreasing cyclosporine dose regimen.

about

P2860

P2860

Salvage therapy of refractory severe aplastic anemia by decreasing cyclosporine dose regimen.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698